JP2005512558A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005512558A5 JP2005512558A5 JP2003553988A JP2003553988A JP2005512558A5 JP 2005512558 A5 JP2005512558 A5 JP 2005512558A5 JP 2003553988 A JP2003553988 A JP 2003553988A JP 2003553988 A JP2003553988 A JP 2003553988A JP 2005512558 A5 JP2005512558 A5 JP 2005512558A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- cap
- group
- tables
- sequence selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical class 0.000 claims 22
- 108090000623 proteins and genes Proteins 0.000 claims 18
- 238000000034 method Methods 0.000 claims 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 11
- 108020004707 nucleic acids Proteins 0.000 claims 11
- 102000039446 nucleic acids Human genes 0.000 claims 11
- 102000004169 proteins and genes Human genes 0.000 claims 9
- 230000000694 effects Effects 0.000 claims 7
- 201000009030 Carcinoma Diseases 0.000 claims 5
- 229940000406 drug candidate Drugs 0.000 claims 5
- 230000000975 bioactive effect Effects 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 239000000523 sample Substances 0.000 claims 3
- 238000012216 screening Methods 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 238000012163 sequencing technique Methods 0.000 claims 2
- 108020004414 DNA Proteins 0.000 claims 1
- 238000000018 DNA microarray Methods 0.000 claims 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000003183 carcinogenic agent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/034,650 US20030216558A1 (en) | 2000-12-22 | 2001-12-20 | Novel compositions and methods for cancer |
| PCT/US2002/041776 WO2003053224A2 (en) | 2001-12-20 | 2002-12-20 | Novel compositions and methods for cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005512558A JP2005512558A (ja) | 2005-05-12 |
| JP2005512558A5 true JP2005512558A5 (https=) | 2006-01-26 |
Family
ID=21877742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003553988A Pending JP2005512558A (ja) | 2001-12-20 | 2002-12-20 | 癌のための新規の組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20030216558A1 (https=) |
| EP (1) | EP1469769A4 (https=) |
| JP (1) | JP2005512558A (https=) |
| AU (2) | AU2002364052B2 (https=) |
| CA (1) | CA2470844A1 (https=) |
| WO (1) | WO2003053224A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030064377A1 (en) * | 2000-11-06 | 2003-04-03 | Yongming Sun | Compositions and methods relating to prostate specific genes and proteins |
| US20030087252A1 (en) * | 2000-12-22 | 2003-05-08 | Morris David W. | Novel compositions and methods in cancer associated with altered expression of PRDM11 |
| US7700274B2 (en) * | 2000-12-22 | 2010-04-20 | Sagres Discovery, Inc. | Compositions and methods in cancer associated with altered expression of KCNJ9 |
| US7820447B2 (en) * | 2000-12-22 | 2010-10-26 | Sagres Discovery Inc. | Compositions and methods for cancer |
| GB2399085A (en) * | 2001-08-02 | 2004-09-08 | Aeomica Inc | Human zinc finger containing gene MDZ12 |
| US20060194265A1 (en) * | 2001-10-23 | 2006-08-31 | Morris David W | Novel therapeutic targets in cancer |
| CA2519227C (en) | 2003-03-19 | 2013-12-03 | Biogen Idec Ma Inc. | Nogo receptor binding protein |
| US8486893B2 (en) | 2004-06-24 | 2013-07-16 | Biogen Idec Ma Inc. | Treatment of conditions involving demyelination |
| HRP20131066T1 (hr) | 2005-07-08 | 2013-12-06 | Biogen Idec Ma Inc. | Sp35 antitijela i njihova upotreba |
| GB0703887D0 (en) * | 2007-02-28 | 2007-04-11 | Bakhiet Abdelmoiz | Immune system mediator |
| CA2729961C (en) | 2008-07-09 | 2018-05-01 | Biogen Idec Ma Inc. | Li113, li62 variant co2, anti-lingo antibodies |
| KR102142161B1 (ko) | 2012-05-14 | 2020-08-06 | 바이오젠 엠에이 인코포레이티드 | 운동 뉴런 관련 병태 치료용 lingo-2 길항제 |
| JP2018504400A (ja) | 2015-01-08 | 2018-02-15 | バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． | Ｌｉｎｇｏ‐１拮抗薬及び脱髄障害の治療のための使用 |
| CN119757761B (zh) * | 2024-12-16 | 2026-03-06 | 新疆医科大学第一附属医院 | 一种鉴别诊断活动性肺结核的生物标志物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6607879B1 (en) * | 1998-02-09 | 2003-08-19 | Incyte Corporation | Compositions for the detection of blood cell and immunological response gene expression |
| AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
| EP1304921A2 (en) * | 2000-06-29 | 2003-05-02 | Deltagen, Inc. | Transgenic mice containing targeted gene disruptions |
| US20030044812A1 (en) * | 2001-01-18 | 2003-03-06 | Walker Michael G. | Cell differentiation cDNAs induced by retinoic acid |
| EP1410011B1 (en) * | 2001-06-18 | 2011-03-23 | Rosetta Inpharmatics LLC | Diagnosis and prognosis of breast cancer patients |
| US20030049623A1 (en) * | 2001-07-18 | 2003-03-13 | Shi Huang | PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use |
-
2001
- 2001-12-20 US US10/034,650 patent/US20030216558A1/en not_active Abandoned
-
2002
- 2002-12-20 WO PCT/US2002/041776 patent/WO2003053224A2/en not_active Ceased
- 2002-12-20 AU AU2002364052A patent/AU2002364052B2/en not_active Ceased
- 2002-12-20 JP JP2003553988A patent/JP2005512558A/ja active Pending
- 2002-12-20 CA CA002470844A patent/CA2470844A1/en not_active Abandoned
- 2002-12-20 EP EP02798629A patent/EP1469769A4/en not_active Withdrawn
-
2008
- 2008-07-31 AU AU2008203436A patent/AU2008203436A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005514923A5 (https=) | ||
| JP2005512558A5 (https=) | ||
| EA020795B1 (ru) | Генетические маркеры, ассоциированные с ответом на интерферон-альфа | |
| CA2488404A1 (en) | Genes and polypeptides relating to human colon cancers | |
| KR101651690B1 (ko) | Ｖｅｇｆ 다형성 및 항―혈관신생 요법 | |
| JP2006518991A5 (https=) | ||
| JP6496003B2 (ja) | Ｆｇｆ−１８化合物に対する応答性を予測するための遺伝子マーカー | |
| KR20160138494A (ko) | Fgfr 융합물 | |
| JP2005522999A5 (https=) | ||
| JP2015535172A (ja) | 軟骨障害の予後バイオマーカー | |
| Mahon et al. | Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction. | |
| JP2006518186A5 (https=) | ||
| JP2008512984A5 (https=) | ||
| WO2016042114A1 (en) | Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis | |
| JP2004533825A5 (https=) | ||
| JP2005511023A5 (https=) | ||
| CA2376666A1 (en) | Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications | |
| JP2005531290A5 (https=) | ||
| JP2005535289A5 (https=) | ||
| JP2008514925A5 (https=) | ||
| JP2017176186A (ja) | 線維症感受性ｉｌ２２ｒａ２遺伝子およびその使用 | |
| JP2005526508A5 (https=) | ||
| JP2006501465A5 (https=) | ||
| JP2005538692A5 (https=) | ||
| JP2009523004A5 (https=) |